Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report

Gabriele Donati; Chiara Abenavoli; Gisella Vischini; Giovanna Cenacchi; Roberta Costa; Gianandrea Pasquinelli; Manuela Ferracin; Noemi Laprovitera; Giorgia Comai; Giorgio Monti; Fabrizio Giostra; Gaetano La Manna

doi:10.12659/AJCR.934220

23 February 2022 : Case report Italy

Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report

Rare coexistence of disease or pathology

Gabriele Donati^1AE, Chiara Abenavoli^1BF, Gisella Vischini^1E, Giovanna Cenacchi^23C, Roberta Costa^23C, Gianandrea Pasquinelli^4C, Manuela Ferracin

^5C, Noemi Laprovitera

^5C, Giorgia Comai^1D, Giorgio Monti^6D, Fabrizio Giostra^6D, Gaetano La Manna^1A*

DOI: 10.12659/AJCR.934220

Am J Case Rep 2022; 23:e934220

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Table 2. Reduction rates per session (RRs,%) of laboratory parameters during HFR-Supra H dialysis.

Parameter	MW (kDa)	RRs (%)	Range (min-max)
Beta 2 microglobulin	12	64.3	55.1–66.7
Procalcitonin	13	41.6	47.0–19.4
Myoglobin	17	57.3	49.1–66.5
Kappa light chains	22.5	56.6	46.6–60.6
Interleukin-6	24	11.1	−39.9–40.7
Lambda light chains	45	32.7	28.7–34.5
Albumin	69	2	0–8
MW – molecular weight; kDa – kilodaltons. All dialysis sessions lasted 240 minutes. The values measured at end of dialysis were corrected for hemoconcentration according to Bergström and Wehle’s formula [].

Back to the Article

Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report

Your Privacy